|
US4018653A
(en)
|
1971-10-29 |
1977-04-19 |
U.S. Packaging Corporation |
Instrument for the detection of Neisseria gonorrhoeae without culture
|
|
US4016043A
(en)
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
|
US4424279A
(en)
|
1982-08-12 |
1984-01-03 |
Quidel |
Rapid plunger immunoassay method and apparatus
|
|
ES2083152T3
(es)
*
|
1990-11-30 |
1996-04-01 |
Monoclonetics Int |
Metodos para el diagnostico de dolores cronicos lumbares y cervicales.
|
|
US5820858A
(en)
|
1993-05-28 |
1998-10-13 |
The Scripps Research Institute |
Methods and compositions for inhibiting CD14 mediated cell activation
|
|
CA2319828A1
(en)
|
1998-01-29 |
1999-08-05 |
Miller, Samuel |
High density arrays for proteome analysis and methods and compositions therefor
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
AU2001255436A1
(en)
|
2000-04-17 |
2001-10-30 |
Transtech Pharma |
Protein expression system arrays and use in biological screening
|
|
GB0022978D0
(en)
|
2000-09-19 |
2000-11-01 |
Oxford Glycosciences Uk Ltd |
Detection of peptides
|
|
US20050130320A1
(en)
|
2000-11-09 |
2005-06-16 |
George Shaji. T. |
Method for identifying the proteome of cells using an antibody library microarray
|
|
AU2001290315A1
(en)
|
2000-11-22 |
2002-06-03 |
Mochida Pharmaceutical Co., Ltd. |
Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
|
|
US6800453B2
(en)
|
2001-01-23 |
2004-10-05 |
President And Fellows Of Harvard College |
Nucleic-acid programmable protein arrays
|
|
WO2003062444A2
(en)
|
2001-11-13 |
2003-07-31 |
Emory University |
Array systems and methods
|
|
JP2005510524A
(ja)
*
|
2001-11-16 |
2005-04-21 |
アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド |
ポリアミン経路の調節による神経変性障害の治療
|
|
AU2003224674A1
(en)
|
2002-03-11 |
2003-09-29 |
Hk Pharmaceuticals, Inc. |
Compounds and methods for analyzing the proteome
|
|
WO2005020784A2
(en)
*
|
2003-05-23 |
2005-03-10 |
Mount Sinai School Of Medicine Of New York University |
Surrogate cell gene expression signatures for evaluating the physical state of a subject
|
|
ES2406266T3
(es)
*
|
2004-05-11 |
2013-06-06 |
Mochida Pharmaceutical Co., Ltd. |
Antígeno CD14 soluble novedoso
|
|
WO2010102412A1
(en)
*
|
2009-03-11 |
2010-09-16 |
Augurex Life Sciences Corporation |
Compositions and methods for characterizing arthritic conditions
|
|
BR112012002333A2
(pt)
*
|
2009-08-06 |
2017-07-18 |
Neuraltus Pharmaceuticals Inc |
método de reduzir os efeitos colaterais e método de potencializar o efeito de um imunomodulador administrado a um sujeito que dele necessita; métodos para tratar doença associada com excesso de ativação de monócitos para macrófagos ativados, diabetes tipo ii ou complicações relacionadas, doença associada com a migração de monócitos ou macrófagos ativados, doença associada a excesso de produção de scd14 e/ou scd163 por macrófagos ativados; composto de cloreto de sódio; composição farmacêutica; método para diagnosticar uma doença relacionada com macrófagos em um sujeito; e método para determinar a eficácia do tratamento com um agente oxidante para uma doença relacionada a macrófagos em um sujeito.
|
|
US8465727B2
(en)
|
2009-10-06 |
2013-06-18 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Biomarkers for the diagnosis of ALS
|
|
EP2501720A2
(en)
*
|
2009-11-18 |
2012-09-26 |
Lascco SA |
Ifn inhibitors in the treatment of motoneuron diseases
|
|
WO2011111043A1
(en)
*
|
2010-03-10 |
2011-09-15 |
Yeda Research And Development Co. Ltd |
Cellular blood markers for early diagnosis of als and for als progression
|
|
WO2012004276A2
(en)
*
|
2010-07-06 |
2012-01-12 |
Fondazione Telethon |
Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits
|
|
US9506923B2
(en)
*
|
2011-08-12 |
2016-11-29 |
Lsi Medience Corporation |
Method of diagnosing surgical site infections
|
|
US10184151B2
(en)
*
|
2011-10-11 |
2019-01-22 |
The Brigham And Women's Hospital, Inc. |
Micrornas in neurodegenerative disorders
|
|
WO2014102333A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Mitsubishi Chemical Medience Corporation |
Use of scd14 or its fragments or derivatives for risk stratisfaction, diagnosis and prognosis
|
|
EP3142674A4
(en)
*
|
2014-05-16 |
2018-01-17 |
Neuraltus Pharmaceuticals, Inc. |
Methods and compositions for treatment of macrophage-related disorders
|
|
WO2016083374A1
(en)
*
|
2014-11-25 |
2016-06-02 |
F. Hoffmann-La Roche Ag |
Biomarkers of fast progression of chronic kidney disease
|
|
HK1250012A1
(zh)
*
|
2015-04-02 |
2018-11-23 |
The Methodist Hospital System |
基於多孔硅微粒的癌症疫苗及增强抗肿瘤免疫的方法
|
|
US10724095B2
(en)
*
|
2015-12-16 |
2020-07-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
|
|
WO2017147378A1
(en)
*
|
2016-02-25 |
2017-08-31 |
The Trustees Of Columbia University In The City Of New York |
Systemic immune activation and biomarkers of nonceliac wheat/gluten sensitivity
|
|
IL309046B2
(en)
|
2017-04-21 |
2025-03-01 |
Implicit Bioscience Ltd |
CD14 antagonist antibodies for the treatment of neurodegenerative diseases
|
|
AU2024238511A1
(en)
*
|
2023-03-21 |
2025-10-02 |
Coya Therapeutics, Inc. |
Biomarkers of amyotrophic lateral sclerosis and uses thereof
|